Sintilimab

DB15765InvestigationalProtein Based Therapies

Sintilimab: Overview.

Mechanism: Pharmacologically active on Programmed cell death protein 1
Curator reviewed
Also known as: Sindilizumab · Sindillimab
Code names: IBI-308

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

604Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Sintilimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.